Objective: To understand the application of echocardiography combined with blood SAA, IL-6, PCT, and CRP detection in the diagnosis and
treatment of Kawasaki disease in children. Methods: 56 children with
Kawasaki disease were selected as the study subjects as the treatment group,
and 54 children with other diseases during the same period were selected as the
control group. Echocardiography, blood SAA, IL-6, PCT and CRP were detected
before and after treatment to observe the results of the two groups. A database
was established to compare the changes of various indicators between the two
groups, as well as the application value of each indicator in the clinical
diagnosis and treatment of Kawasaki disease, and the pros and cons of the
application of each indicator in the diagnosis and treatment of children with
Kawasaki disease were analyzed, so as to
provide a clearer early warning mechanism for the clinical diagnosis and
treatment of children with Kawasaki disease. Results: There was no
significant difference in the results of related imaging indexes in the control
group before and after treatment (P > 0.05). There was no significant
difference in the results of relevant imaging indicators in the treatment group
before and after treatment (P > 0.05), except for LMCA (P < 0.05). The
comparison of imaging related indicators before and after treatment between the
two groups showed that except for no statistically significant difference in
LMCA and RMCA before treatment (P > 0.05), all other indicators had
statistical significance (P < 0.05). The results of relevant laboratory
indexes in control group before and after treatment were statistically significant (P < 0.05). The results of relevant
laboratory indexes before and after
treatment in the treatment group were statistically significant (P < 0.05).
The results of relevant laboratory indicators were compared between the two
groups, except for the results of SAA, IL-6 and PCT before treatment, which
were not statistically significant (P > 0.05), the differences in all other
indicators were statistically significant (P < 0.05). Conclusion: The
combination of echocardiography with blood SAA, IL-6, PCT, and CRP detection
can establish the optimal evaluation plan for accurate and effective diagnosis,
treatment, and
References
[1]
Center for Diagnosis and Treatment of Kawasaki Disease, Children’s Hospital of Shaanxi Provincial People’s Hospital, National Children’s Medical Center, Beijing Children’s Hospital, et al. (2023) Evidence Based Guidelines for the Diagnosis and Treatment of Kawasaki Disease in Chinese Children (2023). Chinese Journal of Contemporary Pediatrics, 25, 1198-1210.
[2]
Dong, M.X., Wang, X.X., Jiao, F.Y. and Zhang, W.H. (2023) Research Advances in Genetic Polymorphisms in Kawasaki Disease. Chinese Journal of Contemporary Pediatrics, 25, 1234-1238.
[3]
McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation, 135, e927-e999.
[4]
Li, B., Cui, T., Li, J., et al. (2023) The Relationship between Myocardial Enzyme Related Indicators, IL-6, BNP, and Coronary Artery Z-Value in Children with Kawasaki Disease and Their Predictive Value for Coronary Artery Disease. International Journal of Laboratory Medicine, 44, 2902-2908+2913.
[5]
Tang, G., Yu, F., Zhang, P.Y., et al. (2023) The Research Progress of Echocardiography Strain Technique in Evaluating the Cardiac Function of Kawasaki Disease. Chinese Imaging Journal of Integrated Traditional and Western Medicine, 21, 711-714.
[6]
Sun, J.J., Wang, L.H., Cao, X.L., et al. (2023) The Diagnostic Value of Ultrasound Automatic Functional Imaging Technology in Evaluating Myocardial Damage in Children with Complete and Incomplete Kawasaki Disease. Journal of China Clinic Medical Imaging, 34, 781-783+798.
[7]
Sun, Q. (2023) The Expression and Changes of Interleukin-6 in the Serum of Children with Kawasaki Disease. Contemporary Chinese Medicine, 30, 110-113.
[8]
Zhou, Y.J., Chen, J., Tan, C.C., et al. (2023) The Role of IL-6, IL-10, and Related Inflammatory Markers in Coronary Artery Injury in Kawasaki Disease. China Health Standard Management, 14, 28-31.
[9]
Yang, F.M., Han, M. and Zhao, Y.L. (2023) The Value Analysis of Three-Dimensional Ultrasound Speckle Tracking Imaging Technology in the Diagnosis of Atypical Kawasaki Disease Coronary Artery Lesions in Children. Knowledge of Cardiovascular Disease Prevention and Treatment, 13, 6-8+11.
[10]
Liu, Y.N., Xia, M., Hu, S.H., et al. (2023) Combined Detection of Lymphocyte Subsets, Inflammatory Factors and N-Terminal B-Type Natriuretic Peptide for the Diagnosis of Kawasaki Disease. Laboratory Medicine, 38, 532-537.
[11]
Wu, R., Xiao, C.S. and Chen, S. (2023) The Value of Combined Detection of CRP, ESR, CKMB, and BNP in Evaluating Coronary Artery Disease in Children with Kawasaki Disease. Journal of Molecular Diagnosis and Therapy, 15, 594-597.
[12]
Min, L., Yuan, S.J., Liu, Y.H., et al. (2023) The Diagnostic Value of Plasma YKL-40, CRP, and IL-6 in Acute Coronary Artery Injury in Children with Kawasaki Disease. Journal of Difficult and Complicated Cases, 22, 367-372.
[13]
Gao, S., Ge, J. and Wang, H.Q. (2023) The Clinical Value of Combining Serum Interleukin-6, Erythrocyte Sedimentation Rate, and Hemoglobin in Predicting Intravenous Immunoglobulin Reactivity in Children with Kawasaki Disease. Chinese Journal of Clinicians, 51, 493-495.
[14]
Wen, Y., Wen, Y.Z., Liu, Y.L., et al. (2023) Study on the Diagnostic Value of Echocardiography in Incomplete Kawasaki Disease in Children. Anhui Medicine and Pharmaceutical Journal, 27, 491-497.
[15]
Huang, X.B., Zhao, S., Zheng, L.Y., et al. (2023) The Predictive Value of Acute Phase Response Proteins SAA and CRP in the Absence of Immunoglobulin Response to Intravenous Injection in Kawasaki Disease. Tianjin Medical Journal, 51, 299-303.
[16]
Ma, P., Liu, C.H., Tang, Q., et al. (2023) The Diagnostic Value of Echocardiography in Evaluating Coronary Artery Injury in Kawasaki Disease. Chongqing Medical Journal, 52, 1702-1706.
[17]
Bing, Z., Wang, X.D., Shan, G.S., et al. (2023) Elevated C-Reactive Protein, Procalcitonin and Decreased Serum Potassium Are Related to the Occurrence and Development of Severe Kawasaki Disease and the Evaluation of Its Clinical Predictive Value. China Journal of Practical Pediatrics, 38, 129-135.
[18]
Zheng, X.Q. (2022) The Value Analysis of Serum C-Reactive Protein and Erythrocyte Sedimentation Rate Detection in the Early Diagnosis of Kawasaki Disease. Chinese Community Doctors, 38, 103-105.
[19]
Cao, J., Liang, H. and Wang, B. (2022) The Value of Echocardiography Combined with ANCA and Cys-C in the Early Diagnosis of Coronary Artery Lesions in Kawasaki Disease. Chinese Journal of Convalescent Medicine, 31, 990-993.
https://doi.org/10.13517/j.cnki.ccm.2022.09.025
[20]
Zhang, D.H., Zheng, L.Y., Yang, G.M., et al (2022) Study on the Expression of Serum NT-proBNP, SAA, CRP and Cysc in Children with Kawasaki Disease and the Predictive Efficacy of Their Combined Detection on the Risk of Coronary Artery Injury. Progress in Modern Biomedicine, 22, 3086-3090.
